Continuum Advisory LLC Has $4.31 Million Holdings in Humana Inc. (NYSE:HUM)

Continuum Advisory LLC lifted its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 19,917.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,612 shares of the insurance provider's stock after purchasing an additional 13,544 shares during the quarter. Continuum Advisory LLC's holdings in Humana were worth $4,311,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in HUM. Creative Financial Designs Inc. ADV grew its stake in Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after acquiring an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. lifted its holdings in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. acquired a new position in shares of Humana in the 3rd quarter valued at approximately $29,000. Ashton Thomas Securities LLC bought a new stake in Humana during the 3rd quarter worth approximately $31,000. Finally, Your Advocates Ltd. LLP raised its holdings in Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after buying an additional 45 shares during the period. Institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

HUM has been the topic of several recent research reports. KeyCorp initiated coverage on Humana in a research note on Friday, October 11th. They issued a "sector weight" rating on the stock. TD Cowen lifted their target price on Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research report on Monday, November 4th. Leerink Partners downgraded Humana from an "outperform" rating to a "market perform" rating and reduced their price target for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Barclays lifted their price objective on shares of Humana from $250.00 to $253.00 and gave the company an "equal weight" rating in a report on Thursday, October 31st. Finally, UBS Group cut their price objective on shares of Humana from $380.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, October 4th. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, Humana currently has a consensus rating of "Hold" and a consensus price target of $315.86.

Humana Stock Performance

Humana stock traded up $4.51 during mid-day trading on Monday, hitting $286.24. 1,058,968 shares of the company's stock traded hands, compared to its average volume of 1,847,223. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a 50 day simple moving average of $272.68 and a two-hundred day simple moving average of $326.83. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $488.89. The stock has a market cap of $34.47 billion, a price-to-earnings ratio of 24.95, a P/E/G ratio of 2.18 and a beta of 0.53.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion during the quarter, compared to analysts' expectations of $28.66 billion. On average, research analysts expect that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.24%. Humana's dividend payout ratio (DPR) is currently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.